GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Baron Funds Comments on IDEXX Laboratories

August 23, 2012 | About:
Holly LaFon

Holly LaFon

254 followers
From Baron Funds' second-quarter letter:

Shares of IDEXX Laboratories, Inc. (IDXX), the leading provider of diagnostics to the veterinary industry, rose during the quarter, driven by improving domestic veterinary trends and progress on resolving an ongoing FTC investigation of its distribution practices. IDEXX reported that domestic foot traffic to veterinarians and practice-level revenues grew year-over-year. The company also announced a revenue-neutral plan to amend its contract with one of its three large distributors, which it believes will alleviate the FTC's concerns.

Rating: 5.0/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide